Acer set to unveil cloud-based remote healthcare solutions at CES
Taiwan-based PC manufacturer Acer is set to unveil a large range of cloud-based healthcare solutions behind its Build Your Own Cloud (BYOC) partners at the Consumer Electronics Show (CES).
At the annual show in Las Vegas, Acer intends to showcase its complete healthcare solutions, which are expected to integrate software and hardware elements. In addition, the company displayed solutions based upon the Acer Open Platform (AOP) with its hardware partners, as application cover everything from health monitoring to remote diagnostics.
RELATED TOPIC: Why the cloud is the safest place to store medical records
“Healthcare has always been a focus of BYOC development,” said BYOC president Maverick Shih. “We expect that long-term healthcare will be a key area in the development of healthcare technology.”
The solutions set to be demonstrated include health monitoring and remote diagnostics. With health monitoring, patients can measure their vital signs or home air quality daily through blood pressure and air quality monitors. This data can be continuously recorded and uploaded to a management platform through the AOP for medical professionals to analyze.
RELATED TOPIC: 4 reasons to take your medical records to the cloud
Meanwhile, remote diagnostics are for those who don’t require intensive medical attention, but still need to be monitored for extended periods. This allows them to interact with medical professionals through smart devices or interactive telepresence equipment for remote diagnostic purposes. Here, vital signs such as blood pressure and blood sugar can be uploaded to a management platform through AOP for recording and analysis.
Acer is working alongside partners in the healthcare sector for the BYOC showcase, which include medical device manufacturer Omron Corp and indoor air quality monitoring device producer CoAsia Microelectronics Corp.
Introducing Dosis - the AI powered dosing platform
Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works.
When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing.
The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced.
What is the Strategic Anemia Advisor?
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease.
SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool.
What else is Dosis working on?
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs.
What are Dosis' strategic goals for the next 2-3 years?
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.
What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.